ROSEN, A LEADING LAW FIRM, Continues to Investigate Securities Claims Against Allakos Inc. – ALLK
Allakos Inc. (ALLK)
Last allakos inc. earnings: 11/12 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.allakos.com/investor-relations
Company Research
Source: Business Wire
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Allakos Inc. (NASDAQ: ALLK) resulting from allegations that Allakos may have issued materially misleading business information to the investing public.On December 18, 2019, Seligman Investments (“Seligman”) published a report describing Allakos as “A Suspect Biotech with a Phase 2 Farce, Incredulous Trial Investigators, and Warning Signs of Potential Fraud.” The Seligman report included 22 warning signs and issues, including Allakos: having “buried the results for the two AK001 studies it conducted, but our research indicates a debacle[;]” having “a checkered history of conducting small, low-credibility trials, marked by . . . discrepancies, omissions, cherry-picking, and other red flags[;]” and engaging in “[f]lagrant nepotism in key clinical roles[.]”On this news, the Company’s stock price fell $13.25, or nearly 10%, to c
Show less
Read more
Impact Snapshot
Event Time:
ALLK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALLK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALLK alerts
High impacting Allakos Inc. news events
Weekly update
A roundup of the hottest topics
ALLK
News
- Kuehn Law Encourages Investors of Allakos Inc. to Contact Law FirmPR Newswire
- All You Need to Know About Allakos (ALLK) Rating Upgrade to Buy [Yahoo! Finance]Yahoo! Finance
- Allakos Provides Business Update and Reports Third Quarter 2024 Financial ResultsGlobeNewswire
- Allakos Announces Phase 1 Trial Results of Subcutaneous AK006 in Healthy VolunteersGlobeNewswire
- Allakos Inc. (NASDAQ: ALLK) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $3.00 price target on the stock.MarketBeat
ALLK
Earnings
- 11/6/24 - Beat
ALLK
Sec Filings
- 12/9/24 - Form 4
- 12/9/24 - Form 4
- 12/6/24 - Form 144
- ALLK's page on the SEC website